These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 2907027)

  • 1. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs.
    Chivers JK; Reavill C; Jenner P; Marsden CD
    J Pharm Pharmacol; 1989 Feb; 41(2):106-11. PubMed ID: 2568417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C; Ogren SO; Haglund L; Angeby T
    Neurosci Lett; 1979 Jun; 13(1):51-6. PubMed ID: 572522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P; Rupniak NM; Marsden CD
    Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
    Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O; Fowler CJ; Köhler C; Ogren SO
    Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.
    Rupniak NM; Mann S; Hall MD; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1984; 84(4):503-11. PubMed ID: 6441951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C; Haglund L; Ogren SO; Angeby T
    J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C; Ogren SO; Fuxe K
    Acta Psychiatr Scand Suppl; 1984; 311():125-37. PubMed ID: 6142588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
    Wilmot CA; Szczepanik AM
    Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
    Satoh H; Kuwaki T; Shirakawa K; Kohjimoto Y; Ono T; Shibayama F; Nomura Y
    Jpn J Pharmacol; 1987 Aug; 44(4):393-403. PubMed ID: 3682405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
    Csernansky JG; Glick S; Mellentin J
    Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of [3H]spiperone binding sites in the rat striatum and frontoparietal cortex by means of quantitative receptor autoradiography after inactivation of dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by sulpiride in the striatum.
    Fuxe K; Meller E; Goldstein M; Benfenati F; Agnati LF
    Neurosci Lett; 1986 Feb; 64(2):163-8. PubMed ID: 3960398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro characterisation of dopamine receptors in the superior colliculus of the rat.
    Weller ME; Rose S; Jenner P; Marsden CD
    Neuropharmacology; 1987 Apr; 26(4):347-54. PubMed ID: 2438586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens.
    Govoni S; Lucchi L; Missale C; Memo M; Spano PF; Trabucchi M
    Brain Res; 1986 Aug; 381(1):138-42. PubMed ID: 3756492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated administration of HA-966 and haloperidol to rats: similar tolerance to striatal dopamine accumulation after HA-966 challenge, but dissimilar effects on striatal [3H]spiperone binding.
    Van der Krogt JA; Van Valkenburg CF; Belfroid RD; Heerkens CB
    Eur J Pharmacol; 1988 Dec; 158(1-2):29-35. PubMed ID: 3220118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO; Hall H; Köhler C; Magnusson O; Lindbom LO; Angeby K; Florvall L
    Eur J Pharmacol; 1984 Jul; 102(3-4):459-74. PubMed ID: 6149133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.